Cancer clinical trials in the region Grand Est
190 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Pancreas cancer
Stomach and esophageal cancer
#NCT04325425
#2024-515300-39-00
Stomach
Neuroendocrine tumor
Metastatic
None
Systemic Treatment-Naive
Chemotherapy
Targeted therapy
Hôpital Simone Veil - CH de Troyes (Troyes)
CHU Dijon
Phase 2
Lymphoma
#NCT05283720
#2023-505347-38-00
B cell lymphoma
Large B cell lymphoma
Indolent transformed lymphoma
None
1
2
3 or more
Bispecific T-cell engager antibodies
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Abbvie
Phase 2
Lymphoma
#NCT05283720
#2023-505347-38-00
B cell lymphoma
Follicular lymphoma
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Abbvie
Phase 2
Lung cancer
#NCT06855771
#2024-519814-29-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
MTAP
1
2
3 or more
Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Bristol-Myers Squibb
Phase 2
Lymphoma
#NCT05952037
#2023-503235-18-00
B cell lymphoma
Waldenström lymphoma
None
None
1
2
3 or more
Systemic Treatment-Naive
Chemotherapy
Targeted therapy
Monoclonal antibodies
CHU Reims (Reims)
BeiGene
Phase 2
Lung cancer
#NCT06840834
#2024-519052-82-00
Mesothelium
Locally Advanced
Metastatic
1
2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Lymphoma
#NCT06271057
#2023-506705-20-00
B cell lymphoma
Large B cell lymphoma
Primary mediastinal lymphoma
Indolent transformed lymphoma
> 60 ml/min
2
3 or more
Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Breast cancer
#NCT06247995
#2023-506717-21-00
HER2 Negative
HR Positive
Metastatic
1
2
3 or more
Targeted therapy
Hormone therapy
Chemotherapy
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg)
Novartis
Phase 2
Lung cancer
#NCT06624059
#2024-511239-91-00
NSCLC (Non-Small Cell Lung Cancer)
Localized
ALK
None
Systemic Treatment-Naive
Surgery
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg)
Hoffmann-La Roche
Phase 2
Lung cancer
#NCT06161441
#2023-505172-29-00
NSCLC (Non-Small Cell Lung Cancer)
Localized
None
Systemic Treatment-Naive
ALK
EGFR
Immunotherapy
Chemotherapy
Radiotherapy
La Polyclinique Gentilly - Nancy - Elsan (Nancy), Hôpital Robert Schuman - UNEOS (Vantoux)
Regeneron Pharmaceuticals